TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - AMGEN | Market Closed - Boerse Frankfurt Warrants 03:36:06 2024-06-19 pm EDT | ||
| 10.97 EUR | -0.36% |
|
| Current month | +0.27% | ||
| 1 month | -5.77% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-19 | 10.95 | -0.54% |
| 24-06-18 | 11.01 | +2.04% |
| 24-06-17 | 10.79 | +4.66% |
| 24-06-14 | 10.31 | -0.19% |
| 24-06-13 | 10.33 | -1.05% |
Real-time Boerse Frankfurt Warrants
Last update June 19, 2024 at 03:36 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SD4L9T |
| ISIN | DE000SD4L9T4 |
| Date issued | 2021-03-12 |
| Strike | 189.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.19 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.32 € |
|---|---|
| Lowest since issue | 3.25 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
306
USD
Average target price
316.4
USD
Spread / Average Target
+3.42%
- Stock Market
- Certificates
- Certificat
